{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:33:23Z","timestamp":1785306803108,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inflammatory myofibroblastic tumour is an infrequent mesenchymal neoplasia of unknown aetiology and variable behaviour, ranging from rather benign lesions to locally aggressive and even metastatic disease. Its presence has been described in almost all organs; however, its location in the female genital tract has rarely been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present the case of a 47-year-old female, who was studied in our institution for a recent medical history of several weeks of dyspareunia and abdominal pain. She underwent pertinent studies including ultrasonography and CT scan. Under suspicion of degenerated leiomyoma, a total hysterectomy was performed. Unexpectedly, the pathological study of the surgical specimen showed very few tumour cells with focal fusiform morphology surrounded by an abundant inflammatory infiltrate; a thorough immunohistochemistry study lead to myofibroblastic tumour of the cervix diagnosis. A PET-CT scan did not show metastatic disease. The patient did not undergo any adjuvant treatment, and she is currently on surveillance with no evidence of disease relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Inflammatory myofibroblastic tumour remains a rare entity yet to be fully elucidated. The diagnosis is based on pathological study due to the lack of typical clinical manifestations and typical radiological images. Surgical resection is the most frequent treatment, whereas chemotherapy and radiotherapy are restricted to locally advanced or metastatic disease. Tirosine kinase inhibitor crizotinib has shown promising results especially in tumours harbouring ALK mutation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02438-5","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T20:02:37Z","timestamp":1637438557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory myofibroblastic tumour of an unusual presentation in the uterine cervix: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Alfonso","family":"L\u00f3pez de Sa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garcia Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"del Arco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00e1nzazu","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pluvio","family":"Coronado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-9787","authenticated-orcid":false,"given":"Gloria","family":"Marquina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"2438_CR1","volume-title":"WHO classification of tumours: soft tissue and bone tumours","author":"C Fletcher","year":"2020","unstructured":"Fletcher C, Bridge J, Antonescu C, Mertens F. WHO classification of tumours: soft tissue and bone tumours, vol. 3. 5th ed. Lyon: International Agency for Research on Cancer; 2020.","edition":"5"},{"key":"2438_CR2","first-page":"85","volume":"15","author":"CM Coffin","year":"1998","unstructured":"Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15:85\u2013101.","journal-title":"Semin Diagn Pathol"},{"key":"2438_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","volume":"29","author":"JT Rabban","year":"2005","unstructured":"Rabban JT, Zaloudek CJ, Shekitka KM, et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005;29:1348\u201355.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2438_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00004347-198709000-00008","volume":"6","author":"CG Gilks","year":"1987","unstructured":"Gilks CG, Taylor GP, Clement PB. Inflammatory pseudotumor of the uterus. Int J Gynecol Pathol. 1987;6(3):275\u201386.","journal-title":"Int J Gynecol Pathol"},{"key":"2438_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1067\/S0002-9378(03)00208-4","volume":"189","author":"Y Azuno","year":"2003","unstructured":"Azuno Y, Yaga K, Suehiro Y, et al. Inflammatory myoblastic tumor of the uterus and interleukin-6. Am J Obstet Gynecol. 2003;189:890\u20131.","journal-title":"Am J Obstet Gynecol"},{"key":"2438_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1440-1827.2006.02018.x","volume":"56","author":"M Shintaku","year":"2006","unstructured":"Shintaku M, Fukushima A. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Pathol Int. 2006;56:625\u20138.","journal-title":"Pathol Int"},{"key":"2438_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejogrb.2011.02.016","volume":"157","author":"S Olgan","year":"2011","unstructured":"Olgan S, Saatli B, Okyay RE, et al. Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review. Eur J Obstet Gynecol Reprod Biol. 2011;157:234\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2438_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.gynor.2013.07.007","volume":"6","author":"CL Kushnir","year":"2013","unstructured":"Kushnir CL, Gerardi M, Banet N, et al. Extrauterine inflammatory myofibroblastic tumor: a case report. Gynecol Oncol Case Rep. 2013;6:39\u201341.","journal-title":"Gynecol Oncol Case Rep"},{"key":"2438_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","volume":"39","author":"C Parra-Herran","year":"2015","unstructured":"Parra-Herran C, Quick CM, Howitt BE, et al. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol. 2015;39:157\u201368.","journal-title":"Am J Surg Pathol"},{"key":"2438_CR10","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1200\/JCO.2013.48.8304","volume":"33","author":"F Fraggetta","year":"2015","unstructured":"Fraggetta F, Doglioni C, Scollo P, et al. Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass. J Clin Oncol. 2015;33:e7\u2013e10.","journal-title":"J Clin Oncol"},{"key":"2438_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-015-0160-2","volume":"8","author":"V Subbiah","year":"2015","unstructured":"Subbiah V, McMahon C, Patel S, et al. STUMP un\u201cstumped\u201d: antitumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol. 2015;8:66.","journal-title":"J Hematol Oncol"},{"issue":"48","key":"2438_CR12","doi-asserted-by":"publisher","first-page":"e8974","DOI":"10.1097\/MD.0000000000008974","volume":"96","author":"VD Mandato","year":"2017","unstructured":"Mandato VD, Valli R, Mastrofilippo V, Bisagni A, Aguzzoli L, La Sala GB. Uterine inflammatory myofibroblastic tumor: more common than expected: case report and review. Medicine. 2017;96(48):e8974.","journal-title":"Medicine."},{"issue":"8","key":"2438_CR13","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1177\/0300060518780873","volume":"46","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Kurosawa M, Uemura M, Kitazawa J, Hayashi Y. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. J Int Med Res. 2018;46(8):3498\u2013503.","journal-title":"J Int Med Res"},{"issue":"2","key":"2438_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/PGP.0000000000000588","volume":"39","author":"S Zarei","year":"2020","unstructured":"Zarei S, Abdul-Karim FW, Chase DM, Sastbury C, Policarpo-Nicolas MLC. Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: a case report. Int J Gynecol Pathol. 2020;39(2):152\u20136.","journal-title":"Int J Gynecol Pathol"},{"key":"2438_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/jcp.2007.049387","volume":"61","author":"BC Gleason","year":"2008","unstructured":"Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428\u201337.","journal-title":"J Clin Pathol"},{"key":"2438_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","volume":"4","author":"CM Lovly","year":"2014","unstructured":"Lovly CM, Gupta A, Lipson D, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4:889\u201395.","journal-title":"Cancer Discov"},{"issue":"2","key":"2438_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/wrr.12398","volume":"24","author":"MK Lichtman","year":"2016","unstructured":"Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016;24(2):215\u201322.","journal-title":"Wound Repair Regen"},{"key":"2438_CR18","doi-asserted-by":"publisher","first-page":"a022293","DOI":"10.1101\/cshperspect.a022293","volume":"10","author":"KK Kim","year":"2018","unstructured":"Kim KK, Sheppard D, Chapman HA. TGF-\u03b21 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10:a022293.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2438_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13287-021-02517-0","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Pan Y, Liu Y, Li X, Tang L, Duan M, et al. Exosomes derived from human umbilical cord blood mesenchymal stem cells stimulate regenerative wound healing via transforming growth factor-\u03b2 receptor inhibition. Stem Cell Res Ther. 2021;12(1):434.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2438_CR20","doi-asserted-by":"publisher","first-page":"452.21.17","DOI":"10.1186\/s13287-020-01971-6","volume":"11","author":"M Duan","year":"2020","unstructured":"Duan M, Zhang Y, Zhang H, Meng Y, Qian M, Zhang G. Epidermal stem cell-derived exosomes promote skin regeneration by downregulating transforming growth factor-\u03b21 in wound healing. Stem Cell Res Ther. 2020;11(1):452.21.17.","journal-title":"Stem Cell Res Ther"},{"key":"2438_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","volume":"363","author":"JE Butrynski","year":"2010","unstructured":"Butrynski JE, D\u2019Adamo DR, Hornick JL, et al. Crizotinib in ALKrearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010;363:1727\u201333.","journal-title":"N Engl J Med"},{"key":"2438_CR22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","volume":"41","author":"JL Pickett","year":"2017","unstructured":"Pickett JL, Chou A, Andrici JA, et al. Inflammatory myofibroblastic tumors of the female genital tract are under-recognized. Am J Surg Pathol. 2017;41:1433\u201342.","journal-title":"Am J Surg Pathol"},{"key":"2438_CR23","doi-asserted-by":"publisher","first-page":"W217","DOI":"10.2214\/AJR.11.7288","volume":"198","author":"M Patnana","year":"2012","unstructured":"Patnana M, Sevrukov AB, Elsayes KM, et al. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol. 2012;198:W217\u201327.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2438_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5858\/arpa.2017-0575-RA","volume":"143","author":"PS Shukla","year":"2019","unstructured":"Shukla PS, Mittal K. Inflammatory myofibroblastic tumor in female genital tract. Arch Pathol Lab Med. 2019;143(1):122\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2438_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","volume":"30","author":"JA Bennett","year":"2017","unstructured":"Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemial and molecular analysis of 13 cases highlighting their broad morphologic spectrum. Mod Pathol. 2017;30(6):1489\u2013503.","journal-title":"Mod Pathol"},{"key":"2438_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","volume":"31","author":"CM Coffin","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509\u201320.","journal-title":"Am J Surg Pathol"},{"key":"2438_CR27","doi-asserted-by":"publisher","first-page":"192e195","DOI":"10.1016\/j.ejca.2018.12.013","volume":"109","author":"J P\u00e9ron","year":"2019","unstructured":"P\u00e9ron J, et al. A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 \u2018CREATE\u2019 trial. Eur J Cancer. 2019;109:192e195.","journal-title":"Eur J Cancer"},{"issue":"6","key":"2438_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-2600(18)30116-4","volume":"6","author":"P Sch\u00f6ffski","year":"2018","unstructured":"Sch\u00f6ffski P, et al. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Lancet Respir Med. 2018;6(6):431\u201341.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2438_CR29","doi-asserted-by":"publisher","first-page":"e12991","DOI":"10.5812\/iranjradiol.12991","volume":"13","author":"B Markovic Vasiljkovic","year":"2016","unstructured":"Markovic Vasiljkovic B, Plesinac Karapandzic V, Pejcic T, Djuric Stefanovic A, Milosevic Z, Plesinac S. Follow-up imaging of inflammatory myofibroblastic tumor of the uterus and its spontaneous regression. Iran J Radiol. 2016;13(1):e12991.","journal-title":"Iran J Radiol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02438-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02438-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02438-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T20:04:12Z","timestamp":1637438652000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02438-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02438-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the presentation of her case along with the associated medical imaging.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}